Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Terprenin: novel immunosuppressant and antiallergic substance under evaluation at Shionogi

Jan. 22, 1999

Antex Biologics receives milestone payment from Pasteur Merieux Connaught

Jan. 21, 1999

FDA committee does not recommend approval of Prograf for GVHD

Jan. 21, 1999

Global FluMist collaboration announced by Aviron and Wyeth Lederle Vaccines

Jan. 14, 1999

Licensing opportunity from RCT: VZV subunit vaccine

Jan. 14, 1999

First vaccine for Lyme disease now available from SB in the U.S.

Jan. 13, 1999

Licensing opportunity from Peptech: anti-TNF antibodies with a range of therapeutic applications

Jan. 13, 1999

SangStat continues to progress with generic ciclosporin formulations

Jan. 12, 1999

Peptide immunomodulators available for licensing from Peptech

Jan. 12, 1999

Eisai prepares novel digalactosylceramide derivatives for multiple indications

Jan. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.